Fluorescent Agent Angiography
Retinal Diseases (Diabetic Retinopathy, AMD)
Preclinical/DiscoveryActive
Key Facts
Indication
Retinal Diseases (Diabetic Retinopathy, AMD)
Phase
Preclinical/Discovery
Status
Active
Company
About MediBeacon
MediBeacon is a private medical device and diagnostics company that has developed a proprietary platform combining fluorescent tracer agents with transdermal sensor technology for non-invasive physiological monitoring. The company achieved a significant milestone with FDA Premarket Approval (PMA) for its Transdermal GFR System, a point-of-care solution for measuring kidney function. Beyond nephrology, MediBeacon is expanding its platform into preclinical research and clinical development for applications in gastroenterology, ophthalmology, and surgery, targeting multiple unmet medical needs with its fluorescence-based technology.
View full company profile